# Effect of a Specific Aquaporin-1 Inhibitor on Vascular Oxidative Stress in Healthy Volunteers

> **NCT06059131** · NA · COMPLETED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 40 (actual)

## Conditions studied

- Oxidative Stress
- Cardiovascular Diseases
- Bacopaside II
- Bacopa Monnieri
- Endothelial Dysfunction
- Aquaporin 1
- AQP1

## Interventions

- **OTHER:** KeenMind
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06059131
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-03
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06059131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06059131, "Effect of a Specific Aquaporin-1 Inhibitor on Vascular Oxidative Stress in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06059131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*